Skip to main content

Arranon

NDC 0078-0683 · Novartis Pharmaceuticals Corporation

Generic namenelarabine
Dosage formINJECTION
RouteINTRAVENOUS
Active ingredient(s)NELARABINE
Strength5 mg/mL
Pharmacologic classNucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
Marketing categoryNDA

Packages

0078-0683-61 — 50 mL in 1 VIAL (0078-0683-61)

Billed under HCPCS

J9261 — Injection, nelarabine, 50 mg Medicare Part B payment limit (ASP + 6%): $65.41

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

25021-259 — Nelarabine, 39822-0650 — Nelarabine, 43598-142 — Nelarabine, 46708-813 — nelarabine, 62332-813 — nelarabine, 66758-165 — nelarabine, 68083-233 — Nelarabine, 70121-1743 — Nelarabine, 70710-1726 — Nelarabine, 70710-1839 — Nelarabine, 70771-1685 — Nelarabine, 71288-165 — Nelarabine, 72205-154 — NELARABINE, 81927-111 — nelarabine, 81927-375 — nelarabine

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels